Vor Biopharma (NYSE:VOR) Price Target Lowered to $22.00 at Robert W. Baird

Vor Biopharma (NYSE:VOR – Get Rating) had its price target lowered by Robert W. Baird from $38.00 to $22.00 in a report released on Friday morning, The Fly reports. The firm currently has an outperform rating on the stock. Several other equities research analysts also recently issued reports on VOR. HC Wainwright cut their target […]

Related Keywords

United States ,America ,Robertw Baird , ,Bourgeon Capital Management ,Corton Capital Inc ,Vor Biopharma Inc ,America Corp ,Thrivent Financial For Lutherans ,Vor Biopharma Company Profile ,Vor Biopharma ,Get Rating ,Moderate Buy ,Capital Management ,Thrivent Financial ,Vor Biopharma Daily ,Nyse Vor ,Kvor ,Medical ,Lower Price Target ,